Sedlek, P. et al. Incidence of adenovirus infection in hematopoietic stem cell transplantation recipients: findings from the AdVance study. Biol. Blood Marrow Transplant. 25, 810818 (2019).

Article PubMed Google Scholar

Hale, G. A. et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transpl. 23, 277282 (1999).

Article CAS Google Scholar

Myers, G. D. et al. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transpl. 39, 677686 (2007).

Article CAS Google Scholar

Myers, G. D. et al. Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transpl. 36, 10011008 (2005).

Article CAS Google Scholar

Rowe, R. G., Guo, D., Lee, M., Margossian, S., London, W. B. & Lehmann, L. Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center. Biol. Blood Marrow Transpl. 22, 12751283 (2016).

Article Google Scholar

Wiriyachai, T. et al. Association between adenovirus infection and mortality outcome among pediatric patients after hematopoietic stem cell transplant. Transpl. Infect. Dis. 23 https://doi.org/10.1111/tid.13742 (2021).

Fan, Z. Y. et al. CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCT. Clin. Exp. Immunol. 208, 332339 (2022).

Article PubMed PubMed Central Google Scholar

Liu, L. W. et al. Letermovir discontinuation at day 100 after allogeneic stem cell transplant is associated with increased CMV-related mortality. Transpl. Cell Ther. 28, 510.e1510.e9 (2022).

Article CAS Google Scholar

Saliba, R. M. et al. Characteristics of graft-versus-host disease (GvHD) after post-transplantation cyclophosphamide versus conventional GvHD prophylaxis. Transpl. Cell Ther. 28, 681693 (2022).

Article CAS Google Scholar

Nunes, N. S. & Kanakry, C. G. Mechanisms of graft-versus-host disease prevention by post-transplantation cyclophosphamide: an evolving understanding. Front Immunol. 10, 2668 (2019).

Article CAS PubMed PubMed Central Google Scholar

Pulsipher, M. A. et al. KIR-favorable TCR-/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial. Blood 140, 25562572 (2022).

Article CAS PubMed PubMed Central Google Scholar

Rambaldi, B. et al. Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide. Blood Adv. 5, 352364 (2021).

Article CAS PubMed PubMed Central Google Scholar

Maeda, Y. Immune reconstitution after T-cell replete HLA haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide. J. Clin. Exp. Hematop 61, 19 (2021).

Article PubMed PubMed Central Google Scholar

Goldsmith, S. R. et al. Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis. Blood 137, 32913305 (2021).

Article CAS PubMed PubMed Central Google Scholar

Kuijpers, T. W. et al. Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency. J. Allergy Clin. Immunol. 140, 273277 e10 (2017).

Article PubMed Google Scholar

Villa, A., Notarangelo, L. D. & Roifman, C. M. Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J. Allergy Clin. Immunol. 122, 10821086 (2008).

Article CAS PubMed Google Scholar

Casanova, J. L. Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc. Natl. Acad. Sci. USA 112, E7128E7137 (2015).

Article CAS PubMed PubMed Central Google Scholar

Marciano, B. E. et al. Common severe infections in chronic granulomatous disease. Clin. Infect. Dis. 60, 11761183 (2015).

Article CAS PubMed Google Scholar

Record, J. et al. Immunodeficiency and severe susceptibility to bacterial infection associated with a loss-of-function homozygous mutation of MKL1. Blood 126, 15271535 (2015).

Article CAS PubMed PubMed Central Google Scholar

Sun, Q., Burton, R., Reddy, V., Lucas, K. G. Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma. Br. J. Haematol. 118, 799808 (2002).

Hanley, P. J. et al. A phase 1 perspective: multivirus-specific T-cells from both cord blood and bone marrow transplant donors. Cytotherapy 18, S8 (2016).

Article Google Scholar

Blyth, E. et al. Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation. Blood 121, 37453758 (2013).

Article CAS PubMed Google Scholar

Leen, A. M. et al. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 114, 42834292 (2009).

Article CAS PubMed PubMed Central Google Scholar

Koehne, G. et al. Immunotherapy with donor T cells sensitized with overlapping pentadecapeptides for treatment of persistent cytomegalovirus infection or viremia. Biol. Blood Marrow Transpl. 21, 16631678 (2015).

Article CAS Google Scholar

Gerdemann, U. et al. Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol. Ther. 21, 21132121 (2013).

Article CAS PubMed PubMed Central Google Scholar

Papadopoulou, A. et al. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci. Transl. Med. 6, 242ra83 (2014).

Article PubMed PubMed Central Google Scholar

Feucht, J., Joachim, L., Lang, P. & Feuchtinger, T. Adoptive T-cell transfer for refractory viral infections with cytomegalovirus, Epstein-Barr virus or adenovirus after allogeneic stem cell transplantation. Klin. Pediatr. 225, 164169 (2013).

Article CAS Google Scholar

Rooney, C. M. et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345, 913 (1995).

Icheva, V. et al. Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J. Clin. Oncol. 31, 3948 (2013).

Article CAS PubMed Google Scholar

Trivedi, D., Williams, R. Y., OReilly, R. J. & Koehne, G. Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy. Blood 105, 27932801 (2005).

Article CAS PubMed Google Scholar

Bollard, C. M. & Heslop, H. E. T cells for viral infections after allogeneic hematopoietic stem cell transplant. Blood 127, 33313340 (2016).

Article CAS PubMed PubMed Central Google Scholar

Hanley, P. J. Build a bank: off-the-shelf virus-specific T cells. Biol. Blood Marrow Transpl. 24, e9e10 (2018).

Article Google Scholar

Tzannou, I. et al. Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr Virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation. J. Clin. Oncol. 35, 35473557 (2017).

Article CAS PubMed PubMed Central Google Scholar

Leen, A. M. et al. Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood 121, 51135123 (2013).

Article CAS PubMed PubMed Central Google Scholar

Barker, J. N. et al. Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood 116, 50455049 (2010).

Article CAS PubMed PubMed Central Google Scholar

Doubrovina, E. et al. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood 119, 26442656 (2012).

Article CAS PubMed PubMed Central Google Scholar

Uhlin, M. et al. Rapid salvage treatment with virus-specific T cells for therapy-resistant disease. Clin. Infect. Dis. 55, 10641073 (2012).

Article CAS PubMed Google Scholar

Naik, S. et al. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J. Allergy Clin. Immunol. https://doi.org/10.1016/j.jaci.2015.12.1311 (2016).

Article PubMed PubMed Central Google Scholar

Uhlin, M., Okas, M., Gertow, J., Uzunel, M., Brismar, T. B. & Mattsson, J. A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation. Cancer Immunol. Immunother. 59, 473477 (2010).

Article PubMed Google Scholar

Qasim, W. et al. Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease. Br. J. Haematol. 154, 150153 (2011).

Article PubMed Google Scholar

Bao, L. et al. Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections. J. Immunother. 35, 293298 (2012).

Article CAS PubMed PubMed Central Google Scholar

Creidy, R. et al. Specific T cells for the treatment of cytomegalovirus and/or adenovirus in the context of hematopoietic stem cell transplantation. J. Allergy Clin. Immunol. 138, 920924.e3 (2016).

Article CAS PubMed Google Scholar

Heslop, H. E. et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 115, 925935 (2010).

Article CAS PubMed PubMed Central Google Scholar

Abraham, A. A. et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 3, 20572068 (2019).

Article CAS PubMed PubMed Central Google Scholar

Withers, B. et al. Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells. Blood Adv. 1, 21932205 (2017).

Article CAS PubMed PubMed Central Google Scholar

Keller, M. D. et al. Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication. Nat. Commun. 15, 2749 (2024).

Styczynski, J. et al. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transpl. 43, 757770 (2009).

Article CAS Google Scholar

Lujan-Zilbermann, J., Benaim, E., Tong, X., Srivastava, D. K., Patrick, C. C. & DeVincenzo, J. P. Respiratory virus infections in pediatric hematopoietic stem cell transplantation. Clin. Infect. Dis. 33, 962968 (2001).

Article CAS PubMed Google Scholar

Chemaly, R. F., Shah, D. P. & Boeckh, M. J. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin. Infect. Dis. 59, S344S351 (2014).

Article CAS PubMed PubMed Central Google Scholar

Crooks, B. N. et al. Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit. Bone Marrow Transpl. 26, 10971102 (2000).

Article CAS Google Scholar

Lamba, R. et al. Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab. Bone Marrow Transpl. 36, 797802 (2005).

Article CAS Google Scholar

Verdeguer, A. et al. Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience. Bone Marrow Transpl. 46, 119124 (2011).

Article CAS Google Scholar

Read the original:
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation ... - Nature.com